Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Infections After HSCT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05471661
What this trial is testing

T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation

Who this might be right for
Opportunistic Fungal InfectionOpportunistic Viral InfectionBone Marrow Transplant Infection
George Papanicolaou Hospital 10
Post-approval studies (Phase 4)Study completedNCT03004261
What this trial is testing

CMV-CTL for the Treatment of CMV Infection After HSCT

Who this might be right for
Cytomegalovirus InfectionsHematological Disease
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 5
Testing effectiveness (Phase 2)Study completedNCT03883906
What this trial is testing

Donor-Derived Viral Specific T-cells (VSTs) for Prophylaxis Against Viral Infections After Allogeneic Stem Cell Transplant

Who this might be right for
Allogeneic Stem Cell TransplantViral Infection
Children's Hospital Medical Center, Cincinnati 30
Not applicableStudy completedNCT00273143
What this trial is testing

A Trial to Study How the Body Fights Off Cytomegalovirus (CMV) in Hematopoietic Transplant Recipients.

Who this might be right for
Cytomegalovirus Infection
Mayo Clinic 50
Testing effectiveness (Phase 2)Study completedNCT02136797
What this trial is testing

Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
CMV InfectionPersistent CMV Viremia
Memorial Sloan Kettering Cancer Center 77
Early research (Phase 1)WithdrawnNCT02276820
What this trial is testing

Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)

Who this might be right for
Adenovirus Infection
AlloVir
Testing effectiveness (Phase 2)Study completedNCT02851576
What this trial is testing

Clinical Grade Adenovirus Specific T Cells for Immunotherapy After Allogeneic Stem Cell Transplantation (CTL-ADV)

Who this might be right for
Adenovirus Infection
Central Hospital, Nancy, France 14
Large-scale testing (Phase 3)Looking for participantsNCT07225972
What this trial is testing

Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone

Who this might be right for
CMVAdV InfectionAdV Reactivation+2 more
New York Medical College 138
Not applicableNo Longer AvailableNCT02822495
What this trial is testing

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

Who this might be right for
Epstein-Barr Virus (EBV) InfectionsLymphoproliferative DisordersEBV+ Associated Lymphoma+9 more
Atara Biotherapeutics
Testing effectiveness (Phase 2)Study completedNCT00049504
What this trial is testing

Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+94 more
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT01295645
What this trial is testing

Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis

Who this might be right for
Transplantation Infection
M.D. Anderson Cancer Center 27
Early research (Phase 1)Study completedNCT00590083
What this trial is testing

Administration of Virus-Specific Cytotoxic T-Lymphocytes

Who this might be right for
Adenovirus Infection
Baylor College of Medicine 14
Not applicableEnded earlyNCT00952185
What this trial is testing

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more
City of Hope Medical Center 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05688241
What this trial is testing

EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases

Who this might be right for
EBV LymphomaPost-transplant Lymphoproliferative Disease (PTLD)
University Hospital, Basel, Switzerland 10
Not applicableStudy completedNCT07181330
What this trial is testing

Clinical Performance of SE-SPTM-PCR in Detecting Hcmv-miR-UL22A-5p After Hematopoietic Stem Cell Transplantation

Who this might be right for
Cytomegalovirus InfectionsHematopoietic Stem Cell Transplantation (HSCT)CMV Reactivation+1 more
Ting YANG 60
Testing effectiveness (Phase 2)Study completedNCT00002941
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Children's Oncology Group 69
Testing effectiveness (Phase 2)Study completedNCT02227641
What this trial is testing

Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation

Who this might be right for
Patients Undergoing Allogeneic Stem Cell Transplantation
University of Erlangen-Nürnberg Medical School 50
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Looking for participantsNCT06909110
What this trial is testing

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus Infections
Jessie L. Alexander 25
Testing effectiveness (Phase 2)Ended earlyNCT03856216
What this trial is testing

Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic LeukemiaB Acute Lymphoblastic LeukemiaLymphocytic Neoplasm+1 more
M.D. Anderson Cancer Center 15
Next Page